SK282252B6 - Piperazínové deriváty a farmaceutický prostriedok s ich obsahom - Google Patents
Piperazínové deriváty a farmaceutický prostriedok s ich obsahom Download PDFInfo
- Publication number
- SK282252B6 SK282252B6 SK889-96A SK88996A SK282252B6 SK 282252 B6 SK282252 B6 SK 282252B6 SK 88996 A SK88996 A SK 88996A SK 282252 B6 SK282252 B6 SK 282252B6
- Authority
- SK
- Slovakia
- Prior art keywords
- piperazine
- methoxy
- ethyl
- methylpyridin
- yield
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR19950000399 | 1995-01-11 | ||
| KR1019950043607A KR0162710B1 (ko) | 1995-01-10 | 1995-11-24 | 신규 피페라진 유도체 및 그 제조방법 |
| PCT/KR1996/000005 WO1996021648A1 (en) | 1995-01-11 | 1996-01-10 | New piperazine derivatives and methods for the preparation thereof and compositions containing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK88996A3 SK88996A3 (en) | 1997-05-07 |
| SK282252B6 true SK282252B6 (sk) | 2001-12-03 |
Family
ID=26630862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK889-96A SK282252B6 (sk) | 1995-01-11 | 1996-01-10 | Piperazínové deriváty a farmaceutický prostriedok s ich obsahom |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5780472A (pl) |
| EP (1) | EP0749425A1 (pl) |
| JP (1) | JP2978967B2 (pl) |
| CN (1) | CN1128139C (pl) |
| AU (1) | AU699619B2 (pl) |
| BR (1) | BR9605309A (pl) |
| CA (1) | CA2184919C (pl) |
| CZ (1) | CZ288002B6 (pl) |
| FI (1) | FI963566A (pl) |
| HU (1) | HUP9602489A3 (pl) |
| NO (1) | NO307459B1 (pl) |
| NZ (1) | NZ298499A (pl) |
| PL (1) | PL183865B1 (pl) |
| RO (1) | RO115159B1 (pl) |
| SK (1) | SK282252B6 (pl) |
| WO (1) | WO1996021648A1 (pl) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6048876A (en) * | 1995-01-23 | 2000-04-11 | Suntory Limited | Medicament for the alleviation or treatment of symptom derived from ischemic disease and compound useful therefor |
| RU2146254C1 (ru) * | 1996-06-29 | 2000-03-10 | Самдзин Фармасьютикал Ко., Лтд. | Производные пиперазина и способ их получения |
| US6174905B1 (en) | 1996-09-30 | 2001-01-16 | Mitsui Chemicals, Inc. | Cell differentiation inducer |
| US6794392B1 (en) | 1996-09-30 | 2004-09-21 | Schering Aktiengesellschaft | Cell differentiation inducer |
| KR100420616B1 (ko) * | 1996-12-26 | 2004-05-17 | 동화약품공업주식회사 | 신규테레프탈산아미드유도체 |
| ES2300151T3 (es) | 1998-09-22 | 2008-06-01 | Astellas Pharma Inc. | Derivados de cianofenilo. |
| EP1075469B1 (en) * | 1999-03-03 | 2004-05-26 | Samjin Pharmaceutical Co., Ltd. | Piperazine derivatives and process for the preparation thereof |
| AU8066701A (en) | 2000-07-20 | 2002-02-05 | Neurogen Corp | Capsaicin receptor ligands |
| DE10035908A1 (de) | 2000-07-21 | 2002-03-07 | Asta Medica Ag | Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel |
| US6432957B1 (en) * | 2001-06-29 | 2002-08-13 | Kowa Co., Ltd. | Piperazine derivative |
| AU2002344951A1 (en) * | 2001-07-02 | 2003-01-21 | Boehringer Ingelheim International Gmbh | Substituted piperazine and diazepanes as histamine h3 receptor agonists |
| IL160974A0 (en) * | 2001-10-22 | 2004-08-31 | Pfizer Prod Inc | Piperazine derivatives with ccr1 receptor antagonist activity |
| JP2005518377A (ja) * | 2001-12-14 | 2005-06-23 | ノボ ノルディスク アクティーゼルスカブ | ホルモン感受性リパーゼの活性を低下させるための化合物の使用 |
| EP2033951A3 (en) | 2002-02-01 | 2009-12-23 | Euro-Celtique S.A. | 2-Piperazine-pyridines useful for treating pain |
| DK1556354T3 (da) | 2002-06-28 | 2008-06-02 | Euro Celtique Sa | Terapeutiske piperazinderivater, der er egnede til behandling af smerter |
| US7262194B2 (en) | 2002-07-26 | 2007-08-28 | Euro-Celtique S.A. | Therapeutic agents useful for treating pain |
| US7157462B2 (en) | 2002-09-24 | 2007-01-02 | Euro-Celtique S.A. | Therapeutic agents useful for treating pain |
| WO2004083235A2 (en) * | 2003-03-19 | 2004-09-30 | Exelixis Inc. | Tie-2 modulators and methods of use |
| KR101287955B1 (ko) * | 2004-12-30 | 2013-07-23 | 얀센 파마슈티카 엔.브이. | 지방산 아미드 하이드롤라제의 조정자로서 피페라지닐 및피페리디닐 우레아 |
| KR101065979B1 (ko) | 2005-02-17 | 2011-09-19 | 아스텔라스세이야쿠 가부시키가이샤 | 피리딜 비방향족 질소 함유 헤테로환-1-카르복실산에스테르 유도체 |
| WO2007005510A1 (en) | 2005-06-30 | 2007-01-11 | Janssen Pharmaceutica N.V. | N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase |
| EP1923388A4 (en) | 2005-08-12 | 2011-03-09 | Takeda Pharmaceutical | BRAIN / NERVE CELL PROTECTION AND THERAPEUTIC FOR SLEEP DISORDERS |
| CA2663984C (en) | 2006-10-18 | 2012-02-21 | Pfizer Products Inc. | Biaryl ether urea compounds |
| BRPI0813331A2 (pt) * | 2007-06-08 | 2014-12-23 | Janssen Pharmaceutica Nv | Derivados de piperidina/piperazina |
| JO2972B1 (en) | 2007-06-08 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Piperidine / piperazine derivatives |
| ES2483898T3 (es) | 2007-06-08 | 2014-08-08 | Janssen Pharmaceutica, N.V. | Derivados de piperidina/piperazina |
| ES2558152T3 (es) | 2007-06-08 | 2016-02-02 | Janssen Pharmaceutica, N.V. | Derivados de piperidina/piperazina |
| TW200924778A (en) * | 2007-10-10 | 2009-06-16 | Takeda Pharmaceutical | Amide compound |
| PE20140572A1 (es) | 2008-06-05 | 2014-05-16 | Janssen Pharmaceutica Nv | Combinaciones de drogas que comprenden un inhibidor de dgat y un agonista de ppar |
| WO2011060026A1 (en) | 2009-11-12 | 2011-05-19 | Jansen Pharmaceutica Nv | Piperazinecarboxamide derivative useful as a modulator of fatty acid amide hydrolase (faah) |
| UA108233C2 (uk) | 2010-05-03 | 2015-04-10 | Модулятори активності гідролази амідів жирних кислот | |
| EP3373935B1 (en) * | 2015-11-12 | 2021-09-01 | Merck Sharp & Dohme Corp. | Cyanopyridine derivatives as liver x receptor beta agonists, compositions, and their use |
| MA46589A (fr) * | 2016-10-24 | 2019-08-28 | Yumanity Therapeutics Inc | Composés et utilisations de ces derniers |
| US11873298B2 (en) | 2017-10-24 | 2024-01-16 | Janssen Pharmaceutica Nv | Compounds and uses thereof |
| EP3914593A4 (en) | 2019-01-24 | 2022-11-02 | Yumanity Therapeutics, Inc. | COMPOUNDS AND THEIR USES |
| JPWO2022118966A1 (pl) * | 2020-12-04 | 2022-06-09 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| OA04700A (fr) * | 1973-05-15 | 1980-07-31 | Rhone Poulenc Sa | Nouveaux dérivés de la naphtyridine et leur procédé de préparation. |
| AU7580187A (en) * | 1986-06-23 | 1988-01-12 | Upjohn Company, The | Androstane-type and cortical aminoesters |
| US4960776A (en) * | 1987-01-28 | 1990-10-02 | A. H. Robins Company, Inc. | 4-aryl-N-(alkylaminoalkyl, heterocyclicamino and heterocyclicamino)alkyl)-1-piperazinecarboxamides |
| JPH02142770A (ja) * | 1988-11-25 | 1990-05-31 | Shigeki Shin | ピペラジン系誘導体 |
| JPH03141258A (ja) * | 1989-10-25 | 1991-06-17 | Kowa Co | 新規なピペラジン誘導体 |
| DE4216364A1 (de) * | 1991-12-14 | 1993-11-25 | Thomae Gmbh Dr K | Neue Pyridylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| US5196428A (en) * | 1992-04-03 | 1993-03-23 | Bristol-Myers Squibb Company | Imidazo[4,5-b]qinolinyl oxy alkyl ureas |
-
1996
- 1996-01-10 BR BR9605309A patent/BR9605309A/pt unknown
- 1996-01-10 HU HU9602489A patent/HUP9602489A3/hu unknown
- 1996-01-10 EP EP96900459A patent/EP0749425A1/en not_active Withdrawn
- 1996-01-10 CZ CZ19962960A patent/CZ288002B6/cs not_active IP Right Cessation
- 1996-01-10 US US08/676,174 patent/US5780472A/en not_active Expired - Lifetime
- 1996-01-10 PL PL96316613A patent/PL183865B1/pl unknown
- 1996-01-10 AU AU44007/96A patent/AU699619B2/en not_active Expired
- 1996-01-10 WO PCT/KR1996/000005 patent/WO1996021648A1/en not_active Application Discontinuation
- 1996-01-10 SK SK889-96A patent/SK282252B6/sk unknown
- 1996-01-10 CA CA002184919A patent/CA2184919C/en not_active Expired - Lifetime
- 1996-01-10 JP JP8521570A patent/JP2978967B2/ja not_active Expired - Lifetime
- 1996-01-10 NZ NZ298499A patent/NZ298499A/en not_active IP Right Cessation
- 1996-01-10 RO RO96-01781A patent/RO115159B1/ro unknown
- 1996-01-10 CN CN96190006A patent/CN1128139C/zh not_active Expired - Lifetime
- 1996-09-10 FI FI963566A patent/FI963566A/fi unknown
- 1996-09-10 NO NO963792A patent/NO307459B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2184919C (en) | 2000-03-14 |
| FI963566A0 (fi) | 1996-09-10 |
| AU4400796A (en) | 1996-07-31 |
| AU699619B2 (en) | 1998-12-10 |
| CZ288002B6 (cs) | 2001-03-14 |
| CN1145620A (zh) | 1997-03-19 |
| HUP9602489A2 (en) | 1997-08-28 |
| SK88996A3 (en) | 1997-05-07 |
| EP0749425A1 (en) | 1996-12-27 |
| RO115159B1 (ro) | 1999-11-30 |
| PL183865B1 (pl) | 2002-07-31 |
| FI963566A (fi) | 1996-09-10 |
| HU9602489D0 (en) | 1996-11-28 |
| WO1996021648A1 (en) | 1996-07-18 |
| CA2184919A1 (en) | 1996-07-18 |
| NO963792D0 (no) | 1996-09-10 |
| PL316613A1 (en) | 1997-01-20 |
| NO963792L (no) | 1996-11-11 |
| JP2978967B2 (ja) | 1999-11-15 |
| NO307459B1 (no) | 2000-04-10 |
| NZ298499A (en) | 1998-01-26 |
| CN1128139C (zh) | 2003-11-19 |
| JPH09511764A (ja) | 1997-11-25 |
| US5780472A (en) | 1998-07-14 |
| CZ296096A3 (en) | 1997-02-12 |
| BR9605309A (pt) | 1997-10-14 |
| HUP9602489A3 (en) | 1998-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK282252B6 (sk) | Piperazínové deriváty a farmaceutický prostriedok s ich obsahom | |
| US6608052B2 (en) | Compounds useful as anti-inflammatory agents | |
| US7235664B2 (en) | Anthranilamides with heteroarylsulfonyl side chain, process of preparation, and use | |
| DE60316686T2 (de) | Bisarylsulfonamid-derivate und ihre verwendung für krebs therapie | |
| DE60312998T2 (de) | 1-amido-4-phenyl-4-benzyloxymethyl-piperidin derivative und verwandte verbindungen als neurokinin-1 (nk-1) antagonsisten zur behandlung von erbrechen, depressionen, angstzustände und husten | |
| KR100396738B1 (ko) | 피페라진 유도체 및 그 제조방법 | |
| US6743788B2 (en) | Carbamate and oxamide compounds | |
| EP1229010A1 (en) | Novel diarylamide derivatives and use thereof as medicines | |
| AU2005219689B2 (en) | Novel cyclic compound having 4-pyridylalkylthio group having (un)substituted amino introduced therein | |
| SK6532003A3 (en) | Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as a medicament, and pharmaceutical preparations containing these compounds | |
| US5872115A (en) | 2-ureido-benzamide derivatives | |
| EP0900789A2 (en) | Substituted quinolone derivatives and pharmaceuticals containing the same | |
| KR20160116009A (ko) | 암 및 증식성 장애들의 치료를 위한 유사분열억제성 아마이드들 | |
| JP4626353B2 (ja) | 置換又は無置換アミノ基を導入した４−ピリジルアルキルチオ基を有する新規環式化合物 | |
| WO2003051866A1 (de) | 2-guanidino-4-heterocyclyl-chinazoline | |
| KR100916160B1 (ko) | 약제학적 항암 조성물 | |
| CZ325196A3 (en) | Derivatives of hydroximic acid, pharmaceutical compositions containing thereof, process of their preparation and intermediates used in the preparation process | |
| JP2010526133A (ja) | ３，４−ジヒドロキナゾリン誘導体 | |
| RU2126001C1 (ru) | Производные пиперазина и фармацевтическая композиция на их основе | |
| KR20120056684A (ko) | 항암활성을 지닌 카르보아졸계 화합물 | |
| KR100197111B1 (ko) | 신규 피페라진 유도체 및 그 제조방법 | |
| US20120094986A1 (en) | Anticancer deriviatives, preparation thereof, and therapeutic use thereof | |
| KR20230163654A (ko) | 벤조퓨라닐 히드록시페닐 메타논 옥심 유도체 및 이의 용도 | |
| TWI426903B (zh) | ２－芳基－４－喹唑啉酮化合物及其醫藥組合物 |